Publications
Academic article
- Tore Salte; Sharad Pathak; Tore Wentzel-Larsen et al. (2011). Increased intracellular growth of Mycobacterium avium in HIV-1 exposed monocyte-derived dendritic cells. (external link)
- David A. van de Vijver; Annemarie M. J. Wensing; Gioacchino Angarano et al. (2006). The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. (external link)
- Pål Voltersvik; Leif Bostad; Anne Ma Dyrhol Riise et al. (2006). Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy. (external link)
- Gkikas Magiorkinis; Konstantinos Angelis; Ioannis Mamais et al. (2016). The global spread of HIV-1 subtype B epidemic. (external link)
- Eva Birgitta Åsjø; Helen Stavang; Birger Sørensen et al. (2002). Phase I Trial of a Therapeutic HIV Type 1 Vaccine, Vacc-4x, in HIV Type 1-Infected Individuals with or without Antiretroviral Therapy. (external link)
- TO Jonassen; Bjørn Grinde; Eva Birgitta Åsjø et al. (2000). Intersubtype recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases. (external link)
- AL Bruu; R Hjetland; E Holter et al. (2000). Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific heterophile antibodies. (external link)
- E Op De Coul; R van den Burg; Eva Birgitta Åsjø et al. (2000). Genetic evidence of multiple transmissions of HIV type 1 subtype F within Romania from adult blood donors to children. (external link)
- Anne Ma Dyrhol-Riise; Pål Voltersvik; Ole G. Berg et al. (2001). Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization. (external link)
- Anne Ma Dyrhol-Riise; AB Brantsaeter; O Dunlop et al. (2000). Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals. (external link)
- Eric Stephen Lugada; Johathan Mermin; F. Kaharuza et al. (2004). Population-based hematologic and immunologic reference values for a healthy Ugandan population. (external link)
- Anne Ma Dyrhol-Riise; Pål Voltersvik; Bård Ingvald Røsok et al. (2000). Normalization of CD4+ Cell Numbers and Reduced Levels of Memory CD8+ Cells in Blood and Tonsillar Tissue after Highly Active Antiretroviral Therapy in Early HIV Type-1 Infection. (external link)
- Dimitrios Paraskevis; Oliver Pybus; Gkikas Magiorkinis et al. (2009). Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. (external link)
- Anne Ma Dyrhol-Riise; Gianna Stent; Bård Ingvald Røsok et al. (2001). The Fas/FasL System and T Cell Apoptosis in HIV-1-Infected Lymphoid Tissue during Highly Active Antiretroviral Therapy. (external link)
- Anne Ma Dyrhol Riise; Pål Voltersvik; Jan Olofsson et al. (1999). Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection. (external link)
- Eric Stephen Lugada; Johathan Mermin; Eva Birgitta Åsjø et al. (2004). Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway. (external link)
- Sharad Pathak; Jane Atesoh Awuh; Nils Anders Leversen et al. (2012). Counting mycobacteria in infected human cells and mouse tissue: a comparison between qPCR and CFU. (external link)
- Annemarie M. J. Wensing; Jürgen Vercauteren; David A. van de Vijver et al. (2008). Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. (external link)
- MV Nilsen; Eva Birgitta Åsjø; Maja A Sommerfelt (1999). Transient Tat activation of the HIVLAV/Lai-1 LTR by primary HIV-1 phenotypic variants in HeLaT4LTR_b-gal cells. (external link)
- Jürgen Vercauteren; Annemarie M. J. Wensing; David A. van de Vijver et al. (2009). Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe. (external link)
- Helge Myrmel; Elling Ulvestad; Birgitta Åsjø (2009). The hepatitis C virus enigma. (external link)
- Sharad Pathak; Gustavo De Souza; Tore Salte et al. (2009). HIV Induces both a Down-Regulation of IRAK-4 that Impairs TLR Signalling and an Up-regulation of the Antibiotic Peptide Dermcidin in Monocytic Cells. (external link)
- L. Marije Hofstra; Nicolas Sauvageot; Jan Albert et al. (2016). Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe. (external link)
- Eva Birgitta Åsjø; Elling Ulvestad (2001). HIV-1 resistens mot antiretrovirale midler. (external link)
- Sharad Pathak; Tore Wentzel-Larsen; Birgitta Åsjø (2010). Effects of in vitro HIV-1 infection on mycobacterial growth in peripheral blood monocyte-derived macrophages. (external link)
- Carol Holm-Hansen; Elly Baan; Eva Birgitta Åsjø et al. (2000). Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region. (external link)
- Carol Holm-Hansen; Beate Stern; Siren Rustad et al. (2000). V3 sequence analysis and biological characterization of HIV-1 isolates from asymptomatic and early symptomatic Tanzanian individuals. (external link)
- Ana B. Abecasis; Annemarie M. J. Wensing; Dimitris Paraskevis et al. (2013). HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. (external link)
- Pål Voltersvik; Anne Ma Dyrhol-Riise; Leif Bostad et al. (2000). Changes in tonsillar tissue in early HIV-1 infection and during 3 years of antiretroviral therapy. (external link)
- Helge Myrmel; Vasanthan Navaratnam; Eva Birgitta Åsjø (2005). Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0). (external link)
- Annemarie M.J. Wensing; David A. van de Vijver; Gioacchino Angarano et al. (2005). Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management. (external link)
- Vidar Ormaasen; Eva Birgitta Åsjø; B Asjo et al. (2004). An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapy. (external link)
- Annemarie Vandamme; Anders Sönnerborg; M Ait-Khaled et al. (2004). Updated European recommendations for the clinical use of HIV drug resistance testing. (external link)
- S Andersson; Eva Birgitta Åsjø; AK Jenum et al. (2004). Relevance of a combined HIV antigen/antibody assay to detect early HIV infection in a low prevalence population: Case reports. (external link)
- Pål Voltersvik; Grethe Albrektsen; Elling Ulvestad et al. (2003). Changes in Immunoglobulin isotypes and Immunoglobulin G (IgG) subclasses during Highly Active Antiretroviral Therapy. Anti-p24 IgG1 closely parallells the biphasic decline in plasma viremia. (external link)
- Kamaldeen Baba; Sharad Pathak; Lisbet Sviland et al. (2008). Real-time quantitative PCR in the diagnosis of tuberculosis in formalin-fixed paraffin-embedded pleural tissue in patients from a high HIV endemic area. (external link)
- Dineke Frentz; David A. van de Vijver; Ana B. Abecasis et al. (2014). Patterns of transmitted HIV drug resistance in Europe vary by risk group. (external link)
- Dineke Frentz; David A.M.C. van de Vijver; Ana B. Abecasis et al. (2014). Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. (external link)
- Kristof Theys; Koen Deforche; Jürgen Vercauteren et al. (2012). Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. (external link)
- Dineke Frentz; Annemarie M. J. Wensing; Jan Albert et al. (2013). Limited cross-border infections in patients newly diagnosed with HIV in Europe. (external link)
- Konstantinos Angelis; Jan Albert; Ioannis Mamais et al. (2015). Global dispersal pattern of HIV type 1 subtype CRF01-AE: A genetic trace of human mobility related to heterosexual sexual activities centralized in southeast Asia. (external link)
Research report
- Inger Sofie Samdal Vik; Susan G. Dudman; Irene Litleskare et al. (2015). Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2013–2014. RAVN 2013-2014. (external link)
- Anette Kilander; Susanne Gjeruldsen Dudman; Kathrine Stene-Johansen et al. (2013). Usage of antivirals and the occurrence of antiviral resistance in Norway 2011-2012. RAVN 2011–12. (external link)
- Gunnar Haukenes; Eva Birgitta Åsjø; H Holm-Samdal et al. (1998). HIV-infeksjon, en strategirapport. (external link)
Letter to the editor
Conference poster
- Eva Birgitta Åsjø; Pål Voltersvik; Leif Bostad (2005). Cathepsin B and Cystatin A as indicators of a separate apoptotic pathway in HIV-1 infection. (external link)
- Pål Voltersvik; Leif Bostad; Anne Ma Dyrhol Riise et al. (2006). Cathepsin B and Cystatin A as indicators of a separate apoptotic pathway in HIV-1 infection. (external link)
- Sharad Pathak; Nils Anders Leversen; Harald G Wiker et al. (2008). Rapid and reliable quantification of Mycobacteria inside macrophages in vitro and mice mice using real-taime quantitative PCR. (external link)
- Sharad Pathak; Nils Anders Leversen; Harald G Wiker et al. (2008). Rapid and reliable quantification of mycobacteria inside macrophages in vitro and mice using real-time quantitative PCR. (external link)
Media interview
- Eva Birgitta Åsjø (2005). Intervju i Dagsnytt 18 om HIV-resistens, Svartedauen och selektion av mutation. (external link)
- Eva Birgitta Åsjø (2005). Fight AIDS @ home. (external link)
- Eva Birgitta Åsjø (2005). Fight AIDS @ home. (external link)
- Eva Birgitta Åsjø (2005). Intervju med anledning av Nelson Mandelas besök och HIV-situationen i Afrika. (external link)
- Eva Birgitta Åsjø (2005). Biodiversitet och nya virus. (external link)
- Eva Birgitta Åsjø (2005). Intervju i Vert å Vite om HIV och bushmeat. (external link)
- Eva Birgitta Åsjø (2005). Intervju i Vert å Vite om nya virus. (external link)